Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Delstrigo (doravirine/lamuvidine/tenofovir disoproxil fumarate)
pCPA File Number:
21115
Negotiation Status:
Concluded with an LOI
Indication(s):
HIV Infection
Sponsor/Manufacturer:
Merck Canada Inc.
CADTH Project Number:
SR0581-000
pCPA Engagement Letter Issued:
2019-06-14
Negotiation Process Concluded:
2019-10-15